This inventor holds 1 USPTO granted patent. Top assignee: Tpo 'Pharmachim'. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: Yordanka T Panova: Innovator in Pharmaceutical Chemistry
Introduction
Yordanka T Panova is a prominent inventor based in Sofia, Bulgaria. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic potential. Her work is characterized by a focus on innovative chemical formulations that can impact health and medicine.
Latest Patents
Yordanka holds a patent for a compound titled 1-(3,4-dimethylbenzyl)-2-(N-alkyl)-carbamoyl tetrahydroisoquinolines. This compound, represented by the formula (I), includes variations where R₁ and R₂ can be hydroxyl or methoxyl, R₃ can be hydrogen or methoxyl, and R₄ can be methyl or chloroethyl. The patent highlights the compound's ability to inhibit adenylate cyclase, showcasing its potential in therapeutic applications.
Career Highlights
Yordanka is associated with TPO Pharmachim, a company that focuses on pharmaceutical development. Her role in the company has allowed her to explore and innovate within the realm of drug formulation and development. With her expertise, she has contributed to advancing the company's research initiatives.
Collaborations
Yordanka has worked alongside notable colleagues, including Chavdar B Ivanov and Donka M Mondeshka. These collaborations have fostered a productive environment for research and innovation, enhancing the impact of their collective work in the pharmaceutical sector.
Conclusion
Yordanka T Panova is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. Her patent for a compound with the ability to inhibit adenylate cyclase exemplifies her contributions to the field. Through her career at TPO Pharmachim and collaborations with esteemed colleagues, she continues to make strides in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile